spacer
home > epc > winter 2003 > current legal issues regarding medicinal products in finland
PUBLICATIONS
European Pharmaceutical Contractor

Current Legal Issues Regarding Medicinal Products in Finland

Reimbursement for Medicinal Products

The latest ruling by the European Court of Justice (ECJ) makes the implementation of procedural changes to the Finnish reimbursement system for medicinal products imminent. The ECJ ruling is connected to the appeal filed to the Commission by Pharma Industry Finland in April 1997 based on the Finnish Government's flawed implementation of the so-called 'Transparency Directive' (89/105/EEC). The Commission brought Finland before the ECJ in June 2000.

In its judgement published on 12th June 2003, the ECJ ruled that Finland has failed to fulfil its obligations under the Transparency Directive. Finland has refused to implement the measures regulating the pricing of and reimbursement for medicinal products with regard to medicinal products that are subject to a higher rate of health insurance coverage.

Finland has a two-phased reimbursement system. In addition to the basic refund group, there are also two special refund categories that include medicinal product or generic medical products that are essential for the treatment of a serious or chronic illness and are eligible for refunds of 75 and 100 per cent. Measured by value of sales, over one-third of all medicines sold in Finland fall into the special refund categories.



Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Johan Еkermarck and Juha Vдyrynen, Partners at Castrйn & Snellman

Johan Еkermarck has handled contractual matters such as licensing, pharmaceutical marketing, advertising, distribution and competition as well as administrative matters, whilst also providing general corporate advice to the pharmaceutical industry.


Juha Vдyrynen is an expert on legal issues involving pharmaceutical, contractual and corporate matters. He recently presented to the Committee for Constitutional Law of Parliament of Finland regarding changes to the Finnish Medicines Act.


spacer
Johan Еkermarck
spacer
spacer
spacer
Juha Vдyrynen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

TrialScope Taps Industry Veteran as CTO

JERSEY CITY, NJ, July 29, 2019 TrialScope, the global leader in clinical trial transparency and compliance solutions, announces the appointment of Ruben Echandy as Chief Technology Officer.
More info >>

White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement